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1. INTRODUCTION
Transgenesis of Caenohabditis elegans (C. elegans, Supplementary
Table 1 for the abbreviated terms) had until recently been a no-
torious problem due to the unstable gene expression affected by
transgene silencing effect (1). However, Mos1 -mediated Single
Copy Insertion (MosSCI) has enabled the generation of stable
transgenic C. elegans lines with one copy of the desired plasmid
inserted into the decided locus of the genome (2). Subsequently
many related techniques and variants have since been reported
(3, 4). All of the transgenic techniques rely on the generation of
transgenes and the cloning procedures are often laborious and
time-consuming. The conventional cloning protocol requires DNA
work including : PCR amplification with the DNA polymerase ; re-
striction enzyme digest ; and insertion into the vector by ligation.
Due to the imperfect fidelity of the DNA polymerase, mutations in
PCR products are often encountered, especially when the ampli-
cons are longer. Sometimes the use of restriction enzymes which
produce unspecific digested ends cannot be avoided, and therefore
the orientation of insertion cannot be specified. Finally the confir-
matory Sanger sequencing is almost always required to confirm
the integrity of cloned DNA. The advent of Gateway cloning has
revolutionalized standard cloning procedures. Gateway cloning was
developed by the research for the site -specific recombination by
the bacteriophage lambda recombination protein Integrase and its
recognition of the “att site” (5). When the phage is integrated into
E. coli genome, attB which stands for the bacterial attachment site
on E. coli chromosome interacts with attP which corresponds to the
specific sequence on the phage genome. Hence the recombination
is referred to as BP reaction, which results in attL and attR sites
which stands for Left and Right attachment site of the integrated
phage. When the phage is excised from E. coli genome, attL site
binds to attR site mediated by the Integrase, and the LR reaction
inversely produces attB and attP sites again (6). Harnessing the
site -specific recombination, the Gateway cloning consists of two
processes. The BP reaction allows cloning of the PCR product
flanked with attB sites into the entry vector with attP sites in the
first step. The second step is the subcloning of the inserted se-
quence, from the entry clone into the destination vector by LR re-
action. The recombination reaction using the integrase poses no
risk of causing any mutations in the cloned DNA fragments, unlike
conventional DNA work with the DNA polymerase. Therefore the
sequence of the insert only needs to be validated once by Sanger
sequencing, after it has been inserted by BP reaction, instead of
sequencing after every step. Therefore once entry clones are gen-
erated they can be easily shuttled into multiple destination vectors,
using the LR reaction, without any sequence validation. Moreover,
there are several subtypes of att site, and each particular att site
can specify the order and partners of recombination among the
entry clones and destination vectors. Thus it allows for multiple
clonings to be performed simultaneously whilst also enabling con-
trol over order, orientation and number of DNA inserts. This prop-
erty has streamlined the large-scale cloning procedure. Especially
in the C. elegans field, previous research has made good use of
Gateway cloning and cloned functional DNA elements in a genome-
wide scale in order to clarify their functions. The results were
published as the milestones of “omics” research known as the
studies of Promoterome, ORFeome and 3’UTRome (7-9). The C.
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elegans researchers adopted the Gateway cloning of the 3- fragment
format, when they pioneered the omics research project (10). Thus,
the entry clones from such libraries can efficiently assemble in the
order of “Promoter : : ORF : : 3’UTR” into destination vectors in a
single reaction (1). MosSCI-compatible vectors were also designed
to serve as the destination vectors of the “user- friendly” Gateway
cloning in the 3-fragment format, taking the genome-wide re-
sources of the libraries into their consideration (2). However, in
other words, this Gateway format constrains the flexibility and re-
fuses any vectors inconsistent with the 3-fragment format. To date,
some variations of Gateway cloning format are commercially avail-
able. They employed different alignment of Gateway att sites from
the format adopted by C. elegans libararies (1). Thus, old legacies
of the entry clone libraries in the 3- fragment format can be hardly
used in the other formats. Due to the necessity of a more flexible
construct which still accepts the C. elegans libraries, we searched
for a new Gateway format and finally established the new recom-
bination format named LeGaSCI (Library-enhanced Gateway for
MosSCI).
2. MATERIALS AND METHODS
2.1. Strains
Wild type C. elegans strain N2 Bristol and strain EG6699 which
carries Mos1 insertion in Chr II were obtained from the Caenorhab-
ditis Genetics Center (CGC ; Minneapolis, MN, USA). #195 worms
which carry the construct Pmyo-2 : : GFP : : UPRT : : unc-54 3’UTR
were generated by the direct insertion method of MosSCI tech-
nique with the strain EG6699 (3).
2.2. Plasmids and Gateway cloning
pCFJ90 and pCFJ68 were obtained from Addgene plasmid
#19327 and Addgene plasmid #19325, respectively (Addgene, USA).
HA-UPRT-pBS and pBCN27-R4R3 were kindly provided by Dr. C.
Doe (11) and Dr. J. Semple (12), respectively. The transgene was
assembled in LeGaSCI format with the combination of MultiSite
Gateway Three-Fragment Vector Construction Kit (Invitrogen,
Gaithersburg, MD, USA, Cat.# 12537-023) and MultiSite Gateway
Pro plus (Invitrogen, Gaithersburg, MD, USA, Cat.# 12537-100).
Briefly, Pmyo-2 promoter, GFP-tag, UPRT and unc-54 3’UTR were
cloned from pCFJ90, pCFJ68, HA-UPRT-pBS and pCFJ90 using
the primer cassettes shown below. Pmyo-2 , F : ggggactgcttttttgt -
acaaacttgcatttctgtgtctgacgatc, R : ggggacaactttgtatagaaaagttg cat-
tttatatctgagtagta. GFP-tag, F : ggggacaagtttgtacaaaaaagcaggcttta-
tgagtaaaggagaagaact, R : ggggacaacttttgtatacaaagttgttttgtatagttcg-
tccatgc. ORF of UPRT, F : ggggacaactttgtatacaaaagttgttatggcgca-
ggtcccagcgag, R : ggggaccactttgtacaagaaagctgggtactacatggttccaa-
agtacc. unc-54 3’UTR, F : ggggacagctttcttgtacaaagtggtt catctcgcg-
cccgtgcctct, R : ggggacaactttgtataataaagttgt aagttggaaacagttatgtt.
The PCR products were cloned into pDONR P4-P1R, pDONR P1-
P5r, pDONR P5-P2 and pDONR P2R-P3 by BP reaction, respec-
tively. 10 ng of each entry clone was subsequently mixed with 150
μg of MosSCI-compatible vector, pBCN27-R4R3. The solution was
filled up to 8 μl with water and 2 μl of the LR clonase was added.
The LR reaction was performed at 25for 24 hours followed by
transformation of E. coli. The resultant construct named #195 was
purified by the standard mini prep protocol.
2.3. Microinjection for MosSCI technique
Microinjection was performed following the protocol of the di-
rect insertion method described in the web page of Wormbuilder
(http : //www.wormbuilder.org/).
3. RESULTS
3.1. The entry vectors of pDONR P1-P5r and pDONR P5-P2
can expand the potential of the MosSCI-compatible vectors to
four-fragment integration
Generally speaking, there are 2 major formats of Gateway clon-
ing, namely the 3- fragment format and the 4-fragment format. The
3-fragment format which MosSCI-compatible vectors belong to
carries the attR4-attR3 cassette in destination vectors whilst the
4- fragment format carries attR1-attR2 cassette in destination vec-
tors and outperforms the flexibility and insertion number for plas-
mid construction conferred by the revised alignment of att sites
(1, 13). Therefore the entry clones designed for one format are not
compatible to another. Although both Gateway formats are used
widely in the world according to any purpose, the 3- fragment for-
mat has more advantage in C. elegans field due to the accessibility
to the genome-wide libraries than the 4-fragment format. Never-
theless, we investigated loopholes for these systems in order to find
the new Gateway format which possesses advantages of both for-
mats. After focusing attention on the combination of each compo-
nent of two formats, it was noticed that entry clones in the middle
position of MosSCI-compatible vectors can be substituted by two
entry clones derived from pDONR P1-P5r and pDONR P5-P2 in
the 4-fragment format, because the entry clones generate the re-
combination intermediate such as attL1 : : fragment 1 : : attB5 : :
fragment 2 : : attL2 by the LR reaction and the middle position in
the 3- fragment format is designed to accept the DNA fragment
flanked with the attL1 and attL2 (Figure 1). It was tempting to in-
vestigate if the new combination of entry clones could perform the
recombination into the attR4-attR3 cassette in the proper order,
that is : Promoter, ORF1, ORF2 and 3’UTR from upstream to down-
stream. pDONR P4-P1R and pDONR P2R-P3 were used to clone
a promoter and a 3’UTR sequence respectively, since the Pro-
moterome and 3’UTRome libraries were cloned in the 3-fragment
format (1). pDONR P1-P5r and pDONR P5-P2 were designed to
clone ORF1 and ORF2, assuming a tag sequence in ORF1 and a
gene of interest in ORF2 for N-terminally tagged proteins or vice
versa for C-terminal tagged proteins. We generated entry clones
that code the myo-2 promoter, a GFP tag, the ORF of UPRT (uracil
phosphoribosyltransferase) and the unc-54 3’UTR , respectively
(2, 11). The four entry clones and a MosSCI-compatible vector,
pBCN27-R4R3, were mixed for the LR reaction and the recombinant
plasmid was purified. Because the usage in Figure 1 is not originally
Supplementary table 1 : The list of abbreviated terms.
The technical or abbreviated terms used in this work are shown in the
list.
abbreviation full name
MosSCI Mos1 -mediated Single Copy Insertion
LeGaSCI Library -enhanced Gateway for MosSCI
att site attachment site
attP the phage attachment site
attB the bacterial attachment site
attL Left attachment site
attR Right attachment site
C. elegans Caenohabditis elegans
E. coli Escherichia coli
UTR untranslated region
GFP green fluorescent protein
UPRT uracil phosphoribosyltransferase
iPAR-CLIP in vivo Photoactivatable -Ribonucleoside -Enhanced
Crosslinking and Immunoprecipitation
T. Kogame 4-fragment Gateway with C. elegans libraries162
(#195)  Pmyo-2 :: GFP :: UPRT :: unc-54 3'UTR in pBCN27 
Pmyo-2 GFP UPRT unc-54 3’UTR 
1 2 3 
Linker: attB1 GFP Pmyo-2
1 
Linker: attB5 GFP UPRT 
2 
Linker: attB2 UPRT unc-54 3’UTR 
3 
Multisite Gateway Pro MultiSite  Gateway
3 fragments 2 fragments 
4 fragments 
1 2 3 4 
attL4 
attR4 
attL1 
attR1 
attL5 
attR5 
attR2 
attL2 
attL3 
attR3 
intended by the manufacturer, it was necessary to confirm the pre-
cise sequence of the resulting construct by Sanger sequence. The
sequence result showed the orderly alignment of the four frag-
ments (Pmyo-2 : : GFP : : UPRT : : unc-54 3’UTR in pBCN27). The
recombinant linker sequences derived from the att sites of the
entry clones were also yielded without unexpected mutations
(Figure 2).
We confirmed that the new Gateway format recombines four
entry clones into a single MosSCI-compatible vector without any
inversion, deletion or mutation of the inserted fragments. Addi-
tionally, this indicates that the primer design for the BP reaction
complies with the original protocol and does not require any modi-
fication. The new Gateway format was named LeGaSCI (Library-
enhanced Gateway for MosSCI).
3.2. The recombinant construct served as a translational gene
fusion vector in MosSCI technique
MosSCI is one of the most reliable techniques to generate sta-
ble transgenic lines of C. elegans (1, 2). Thus LeGaSCI format can
improve the flexibility of vector-design for MosSCI and enables the
streamlining of the generation of stable transgenic lines carrying
more complex transgenes. We next investigated if the recombinant
construct can generate stable transgenic lines using MosSCI.
MosSCI was performed with the recombinant construct shown in
Figure 2 (Pmyo-2 : : GFP : : UPRT : : unc-54 3’UTR in pBCN27). It
was designed to express GFP-tagged UPRT protein in the phar-
ynx. Thus the GFP signal should only be seen in the pharynx of
MosSCI lines. After microinjection was performed with the recom-
binant construct, the stable transgenic MosSCI lines were selected
by recovery of unc-119 mutant phenotype and loss of negative se-
lection markers according to the MosSCI technique protocol (3).
The GFP signal from the generated MosSCI line was searched
under the fluorescent microscope. The pharynx in the MosSCI
line exhibited high intensity GFP signal whereas no signal was
observed in wild type (Figure 3). This indicates GFP-tagged UPRT
protein was tissue-specifically expressed in the pharynx as intended.
Collectively, the recombinant construct generated in LeGaSCI
format was confirmed to serve as a translational gene fusion vec-
tor in MosSCI. Thus we have established the more flexible 4-
fragment new Gateway format, which can accept the Promoterome
and 3’UTRome libraries.
DISCUSSION
Here the 4-fragment Gateway format optimized for C. elegans
MosSCI named LeGaSCI is established. It augments the potentials
of MosSCI by coupling flexibility of the insert number, with the
widest accessibility to entry clones, allowing insertion of the Pro-
moterome as well as the 3’UTRome libraries, which are both pub-
licly available (1). Further 13 MosSCI vectors were successfully
generated in LeGaSCI format without any mutations detected upon
Sanger sequencing (Supplementary table 2 and 3). This indicates
that LeGaSCI format can accept any entry vectors from the genome-
wide libraries. LeGaSCI format is particularly intended for the
Figure 1 : A new recombination platform integrates existing genome-
wide C. elegans Promoterome and 3’UTRome libraries.
A : Four - fragment recombination allows integration of Promoterome
library (position 1), ORF1 and ORF2 (positions 2 and 3) and 3’UTRome
library (position 4) to allow easy construction of C. elegans transgenes for
tissue-specific expression of tagged proteins (ORF1 fused to ORF2).
Figure 2 : Sanger sequencing revealed that each fragment was
assembled with linker sequences as intended.
A confirmatory sequence showed that the 4 fragments from entry vec-
tors were assembled in the expected position without inversion or trun-
cation and that the recombinant linker sequences carry no mutations
such as deletion, insertion or flame-shift mutation.
Figure 3 : The MosSCI line generated by the construct exhibited
the high intensity signal of GFP in the pharynx.
Bright field (BF) and GFP fluorescence microscopy of wild - type N2 and
MosSCI line #195 (carrying the construct of Pmyo-2 : : GFP : : UPRT : :
unc-54 3’UTR in pBCN27). The wild - type N2 shows the slight back-
ground signal from the gut, whilst #195 indicated the high intensity sig-
nal of GFP from the pharynx. The high magnification image delineates
the shape of the pharynx which the myo-2 promoter is known to drive
the gene expression in.
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construction of tagged protein expression vectors for. In order to
construct MosSCI vectors expressing tagged proteins, the transla-
tional PCR fusion (also known as overlap extension PCR or PCR
stitching) is recommended as a standard procedure (1). Sequences
of the tag and the gene of interest are stitched by PCR and sub-
cloned into one of the three entry vectors. Hence the 3-fragment
format has two more slots in which to accept the entry clones in-
cluding the libraries. However, the confirmatory Sanger sequence
should be repeated for the subcloned tag sequence owing to the
theoretically imperfect fidelity of the DNA polymerase. Thus, this
procedure requires duplication of effort and becomes the bottleneck
of high-throughput cloning using the Gateway system. On the other
Supplementary table 3 : The list of the construct for MosSCI.
With the entry clones shown in the supplementary table 2, 13 MosSCI constructs were generated besides the construct indicated in the main text.
Construct Cloned sequence Slot1 Slot2 Slot3 Slot4 Backbone vector
#124 Ppie-1 : : luc : : A(3) - tag : : glh-2 3’UTR A8 : Ppie-1 B4 : luciferase C1 : A(3) - tag D1 : glh-2 3’UTR pCFJ150
#145 Ppie-1 : : mCherry : : OsTIR : glh-2 3’UTR A8 : Ppie-1 B6 : mCherry C5 : OsTIR D1 : glh-2 3’UTR pCFJ150
#148 Phsp-16.48 : : GFP : : TEV : : glh-2 3’UTR A2 : Phsp-16.48 B7 : GFP C6 : TEV D1 : glh-2 3’UTR pCFJ150
#150 Ppie-1 : : GFP : : UPRT : : glh-2 3’UTR A8 : Ppie-1 B7 : GFP C7 : UPRT D1 : glh-2 3’UTR pBCN27-R4R3
#151 Ppie-1 : : luc : : GFP : : glh-2 3’UTR A8 : Ppie-1 B4 : luciferase C2 : GFP D1 : glh-2 3’UTR pCFJ150
#152 Ppie-1 : : luc : : mCherry : : glh-2 3’UTR A8 : Ppie-1 B4 : luciferase C3 : mCherry D1 : glh-2 3’UTR pCFJ150
#158 Phsp-16.48 : : GFP : : TEV : : tbb-2 3’UTR A2 : Phsp-16.48 B7 : GFP C6 : TEV D3 : tbb-2 3’UTR pBCN27-R4R3
#176 Ppei -1 : : A(5) - tag : : GFP : : tbb-2 3’UTR A8 : Ppie-1 B3 : A(5) - tag C2 : GFP D3 : tbb-2 3’UTR pBCN27-R4R3
#192 Pmyo-2 : : A(5) - tag : : GFP : : unc-54 3’UTR A1 : Pmyo-2 B3 : A(5) - tag C2 : GFP D2 : unc-54 3’UTR pCFJ210
#194 Phsp-16.48 : : GFP : : OsTIR : : unc-54 3’UTR A2 : Phsp-16.48 B7 : GFP C5 : OsTIR D2 : unc-54 3’UTR pBCN27-R4R3
#195 Pmyo-2 : : GFP : : UPRT : : unc-54 3’UTR A1 : Pmyo-2 B7 : GFP C7 : UPRT D2 : unc-54 3’UTR pBCN27-R4R3
#196 Phsp-16.48 : : GFP : : UPRT : : unc-54 3’UTR A2 : Phsp-16.48 B7 : GFP C7 : UPRT D2 : unc-54 3’UTR pBCN27-R4R3
#197 Pglh-2 : : GFP : : HA-UPRT : : unc-54 3’UTR A3 : Pglh-2 B7 : GFP C7 : UPRT D2 : unc-54 3’UTR pBCN27-R4R3
#198 Phis-72 : : GFP : : HA-UPRT : : tbb-2 3’UTR A7 : Phis-72 B7 : GFP C7 : UPRT D3 : tbb-2 3’UTR pBCN27-R4R3
Supplementary table 2 : The list of the entry clones.
Entry clones were generated as indicated or obtained from Addgene (USA).
Entry clones Cloned sequence PCR template Backbone vector Fwd primer Rvs primer
A1 Pmyo - 2 pCFJ90 pDONR P4 - P1R GGGGACAACTTTGTATAGAAAAGTTGatttctgtgtctgacgatc
GGGGACTGCTTTTTTGTACAAACTTG
cattttatatctgagtagta
A2 Phsp - 16.48 pJL44 pDONR P4 - P1R GGGGACAACTTTGTATAGAAAAGTTGtggacggaaatagtggtaaa
GGGGACTGCTTTTTTGTACAAACTTG
tcttgaagtttagagaatga
A3 Pglh - 2 pJL43.1 pDONR P4 - P1R GGGGACAACTTTGTATAGAAAAGTTGgaattcatattaccattatt
GGGGACTGCTTTTTTGTACAAACTTG
tacaagtttggcgtttgcaa
A7 Phis - 72 C. elegans Genome pDONR P4 - P1R GGGGACAACTTTGTATAGAAAAGTTGttaaattgagaattgagaatgg
GGGGACTGCTTTTTTGTACAAACTTG
ttggctgagtatcaaacgtta
A8 Ppie - 1 pCM1.127* pDONR P4 - P1R
B3 A(5) - tag pMK38 pDONR P1 - P5r GGGGACAAGTTTGTACAAAAAAGCAGGCTTTatgatgggcagtgtcgagct
GGGGACAACTTTTGTATACAAAGTTGT
cactttatgcttccggctcg
B4 luciferase SCP2_CMVenh - luc - 1 (22) pDONR P1 - P5r GGGGACAAGTTTGTACAAAAAAGCAGGCTTTatggaagacgccaaaaacat
GGGGACAACTTTTGTATACAAAGTTGT
cacggcgatctttccgccct
B6 mCherry pCFJ104 pDONR P1 - P5r GGGGACAAGTTTGTACAAAAAAGCAGGCTTTatggtctcaaagggtgaaga
GGGGACAACTTTTGTATACAAAGTTGT
cttatacaattcatccatgc
B7 GFP pCFJ68 pDONR P1 - P5r GGGGACAAGTTTGTACAAAAAAGCAGGCTTTatgagtaaaggagaagaact
GGGGACAACTTTTGTATACAAAGTTGT
tttgtatagttcgtccatgc
C1 A(3) - tag pMK43 (23) pDONR P5 - P2 GGGGACAACTTTGTATACAAAAGTTGTTatgatgggcagtgtcgagc
GGGGACCACTTTGTACAAGAAAGCTGGGTA
tcaagctctgctcttgcact
C2 GFP pCFJ68 pDONR P5 - P2 GGGGACAACTTTGTATACAAAAGTTGTTatgagtaaaggagaagaact
GGGGACCACTTTGTACAAGAAAGCTGGGTA
ttatttgtatagttcgtc
C3 mCherry pCFJ104 pDONR P5 - P2 GGGGACAACTTTGTATACAAAAGTTGTTatggtctcaaagggtgaaga
GGGGACCACTTTGTACAAGAAAGCTGGGTA
ttacttatacaattcatcca
C5 OsTIR pNHK36 (23) pDONR P5 - P2 GGGGACAACTTTGTATACAAAAGTTGTTatgacgtacttcccggagga
GGGGACCACTTTGTACAAGAAAGCTGGGTA
ctataggattttaacaaaat
C6 TEV pDS5 (24) pDONR P5 - P2 GGGGACAACTTTGTATACAAAAGTTGTTatggcgatgcaagcggccaa
GGGGACCACTTTGTACAAGAAAGCTGGGTA
ttacaattgagtcgcttcct
C7 UPRT pbluescript -HA -UPRT pDONR P5 - P2 GGGGACAACTTTGTATACAAAAGTTGTTatggcgcaggtcccagcgag
GGGGACCACTTTGTACAAGAAAGCTGGGTA
ctacatggttccaaagtacc
D1 glh - 2 3’UTR pJL43.1 pDONR P2R -P3 GGGGACAGCTTTCTTGTACAAAGTGGTTcttgtccatattgtatcagta
GGGGACAACTTTGTATAATAAAGTTGT
gcaaaaaaatgaatcataac
D2 unc - 54 3’UTR pCFJ90 pDONR P2R -P3 GGGGACAGCTTTCTTGTACAAAGTGGTTcatctcgcgcccgtgcctct
GGGGACAACTTTGTATAATAAAGTTGT
aagttggaaacagttatgtt
D3 tbb - 2 3’UTR pCM1.36* pDONR P2R -P3
* : plasmids obtained from Addgene (USA)
Numbers in parentheses indicate numbers of references
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hand, without re-sequencing, tagged protein expression vectors
are assembled from entry clones, in a single LR reaction, once a
repertoire of entry clones for the validated tag-coding sequences
has been prepared in LeGaSCI format.
C. elegans researchers suffer from insufficient resources of an-
tibodies against many sorts of native proteins. The tag sequence
can also be used as the affinity tag for protein purification. Thus
the solution for the issue is to use transgenic lines that express
fusion proteins with affinity tags against which antibodies are read-
ily available. Therefore LeGaSCI format aids genome-wide scale
experiments in C. elegans, and allows streamlining and simplifi-
cation of the process. For instance, recently the novel method,
“iPAR-CLIP” was established by one group (15). As the name
suggests, the experiments are based on the technique of Cross-
Linking and Immunoprecipitation which purifies the binding part-
ners of the target molecule. Thus they cross- linked the RNA mole-
cules bound to the protein of interest and purified them. They then
annotated all the RNA bound to the protein by a deep sequencer.
The technique takes advantage of the C. elegans transgenic line
which expresses the Gld-1 : : GFP : : FLAG fusion protein. They
performed CLIP with the anti -FLAG antibody and clarified genome-
wide mRNAs bound to the Gld-1 protein. Thus LeGaSCI format
can provide easy production of transgenic lines for any tagged pro-
tein. Because of the apparent necessity for transgenic lines express-
ing tagged proteins in the C. elegans field, one group has already
launched the genome-scale project, TransgenOme for the tag-
based analysis of genome-wide transgene behavior. They used the
fosmid library which is designed for expression vectors of C-
terminally GFP-tagged proteins because the fosmids usually con-
tain approximately 35-40 kb stretch of genomic sequences which
encompass the intact regulatory elements. They generated the
transgenic lines with the fosmid constructs and clarified multiple
gene behaviors with transgenic lines of 230 different genes (16).
The project is still ongoing and constantly increasing the number
of strains available for the public, however it has yet to be com-
pleted for as many as approximately 20000 genes (17). Therefore
you may not be able to obtain the transgenic lines of interest from
the TransgenOme repository. Moreover, modification of the tag
can be required in CLIP experiments since it is known that the tag
sequence can interfere with protein folding and alter the conforma-
tion. Although a lot of the protocols to generate fosmid constructs
are described in literature, it is not as easy as Gateway cloning
(18). Thus LeGaSCI format can provide easier access to transgenic
resources than TransgenOme library in some contexts.
C. elegans is a multicellular organism, with a transparent body,
hence fluorescent proteins such as GFP can be easily used to
monitor gene expression, giving information on tissue-specificity.
Thus C. elegans was used to monitor the spatial and temporal regu-
lation of in vivo gene function using fluorescent proteins. Such
transgenic approaches, especially in the high-throughput setting,
always suffer from experimental noise due to the artificial manipu-
lation of a living system. Hence it is essential to recapitulate the
gene functions in a more reliable experimental design. Though the
C. elegans Promoterome studies revealed promoter activity in a
genome-wide scale, part of the results from the promoter : : re-
porter constructs conflict the data from the reporter lines of the
TransgenOme, whose constructs carry intact gene structure and
the native regulatory elements (16). This clearly indicates the im-
portance of regulatory elements outside of promoters. Furthermore,
many reports clarified that the 3’UTR plays important roles in regu-
lating gene expression, especially in the gonadal and embryonic
stages in C. elegans (19, 20). Thus integration of the regulatory
elements is fundamentally important to monitor gene behaviors in
the developmental stage. Previous researchers used C. elegans as
the platform to analyze splicing isoform of genome-wide transcripts
in order to recapitulate the spatial and temporal regulation of the
gene expression in vivo. They established the method to generate
fluorescent alternative splicing reporters (21). The reporter con-
struct in the method was designed with Gateway destination vec-
tor carrying attR1-attR2 cassette. For the control of tissue specific-
ity, they constructed 20 destination vectors that possess different
kinds of promoters and 3’UTRs for major tissues in order to con-
duct genome- and organism-wide applications. Hence 20 destina-
tion vectors provide with the resolution of tissue-specificity, which
enables the analysis of the expression profile of the splicing iso-
forms. However, we can not exclude the experimental noise owing
to imperfect regulatory elements for gene regulation in the ap-
proach, and strategy can be improved by constructing reporter
transgenes with regulatory elements more specific to tissue or cell
types. Promoterome library consists of6000 promoters for pre-
dicted genes and 3’UTRome library is composed of 3’UTRs for
7105 CDSs (6741 genes) (7, 9). Hence, LeGaSCI format can pro-
vide literally countless combination of regulatory element compo-
nents, and therefore augments the resolution of tissue- or cell
type-specific analysis by the number of the combination. There is
another point to consider in regards to experimental noise : The
previous reporter constructs conducted for genome-wide analysis
such as TransgenOme are not designed for MosSCI. Therefore
they do not ensure one copy insertion in the decided locus of the
genome whilst the new format can avoid this issue. In conclusion,
combining MosSCI and regulatory elements from the libraries can
thus provide one of the most reliable platforms to monitor the gene
expression using fluorescent tagged proteins (Figure 4).
Collectively, we established the new Gateway format named
LeGaSCI intended for tagged proteins, integrating the regulatory
elements from the Promoterome and 3’UTRome libraries. LeGaSCI
format adds more flexibility to the designing of C. elegans trans-
genic lines while it streamlines the time-consuming cloning proc-
ess. We believe LeGaSCI format allows the realization of the po-
tential of the C. elegans libraries in genome-wide researches and
expands the field of C. elegans in life science to more complex
applications with more high-throughput experimental designs.
Figure 4 : The Overview of the “LeGaSCI” format.
The 2 slots in the middle of MosSCI- compatible vectors enable to flex-
ibly design the various tagged proteins once tags are cloned in LeGaSCI
format. The entry clones from Promoterome and 3’UTRome libraries are
integrated into the format in suitable order as protein expression vectors,
which allows to design the fine - tuned gene expression by the regulatory
elements.
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